Close Brothers Group plc (CBG)
London Exchange · UK · prices in GBX · close of 23 Oct 2026
Key indicators
| Last close | GBX 378.40 |
|---|---|
| 52-week range | 318.40 – 556.15 |
| Return, 1 month / 3 months | −1.9% / −8.8% |
| Return, 1 year / 3 years | −12.9% / −50.2% |
| Trend | Below its 200-day average |
| RSI (14) | 45 |
| Volatility (1 year) | 44.9% |
| Worst drawdown (1 year) | -35.5% |
| Average daily value traded | 182.51M GBX |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Close Brothers Group is a British merchant banking group based in London. Through its banking division it provides lending to small and medium-sized businesses and to individuals, including motor finance, asset finance and invoice finance. The group also runs asset management services for private clients and institutions, and a securities trading business that makes markets in equities and fixed income. Its customers are mainly companies, professional firms and private individuals in the United Kingdom.
Close Brothers Group plc trades under the code CBG on the London Exchange in UK, with its price quoted in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Close Brothers Group plc (CBG) trades on the London Exchange in UK. It last closed at GBX 378.40 on 23 October 2026.
Its price-based Market X-Ray is 40 out of 100 (a weak price profile), ranking 2,651 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 12.9% and over the last three months it fell 8.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 26 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -13.3% | ||
| From 52-week high | -29.3% | ||
| Momentum | 27 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -8.8% | ||
| 6-month return | -18.1% | ||
| 12-month return, skipping the last month | -11.2% | ||
| Stability (higher is calmer) | 36 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 44.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -35.5% | ||
| Liquidity | 92 · Strong | Trades actively. | |
| Average daily value traded | 182.51M GBX | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 2 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | +0.3% |
|---|---|
| 1 month | −1.9% |
| 3 months | −8.8% |
| 6 months | −18.1% |
| 1 year | −12.9% |
| 3 years | −50.2% |
| 5 years | −74.0% |
Signals
| 50-day / 200-day average | 401.20 / 436.27 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 15.00 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 19 Oct 2023 | GBP 0.4500 |
| 23 Mar 2023 | GBP 0.2250 |
| 13 Oct 2022 | GBP 0.4400 |
| 24 Mar 2022 | GBP 0.2200 |
| 14 Oct 2021 | GBP 0.4200 |
| 25 Mar 2021 | GBP 0.1800 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.